JPH03158176A - Cancer medical treating device - Google Patents

Cancer medical treating device

Info

Publication number
JPH03158176A
JPH03158176A JP1296679A JP29667989A JPH03158176A JP H03158176 A JPH03158176 A JP H03158176A JP 1296679 A JP1296679 A JP 1296679A JP 29667989 A JP29667989 A JP 29667989A JP H03158176 A JPH03158176 A JP H03158176A
Authority
JP
Japan
Prior art keywords
magnetic field
magnetic
magnetic pole
affected part
pole pairs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1296679A
Other languages
Japanese (ja)
Inventor
Takao Yamamuro
山室 隆夫
Tadashi Kokubo
正 小久保
Mitsusachi Abe
阿部 光幸
Koichiro Oura
大浦 好一郎
Masahiro Hiraoka
眞寛 平岡
Michiya Yamashita
道也 山下
Akiyoshi Yonetani
米谷 章義
Yukihiro Ebisawa
海老沢 幸弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Steel Corp
Original Assignee
Sumitomo Metal Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Metal Industries Ltd filed Critical Sumitomo Metal Industries Ltd
Priority to JP1296679A priority Critical patent/JPH03158176A/en
Publication of JPH03158176A publication Critical patent/JPH03158176A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To perform enough high-efficient heating of the affected part, where a material having a high magnetic hysteresis loss is caused to deposit and reside, of an organism by a method wherein a cancer medical treating device comprises magnetic pole pairs for generating an AC magnetic field positioned facing each other in a position, where an affected part is nipped therebetween, in a manner to regulatable of a clearance, a magnetic field applying part to apply an AC magnetic field on the magnetic pole pair, and a magnetic field control part to control an AC magnetic field. CONSTITUTION:Magnetic pole pairs are arranged so that an affected part 32 is positioned between magnetic pole pairs 14 and 14''. It is desirable from a point of view of heating efficiency that a clearance between the tip parts of the two magnetic pole pairs is decreased to a value as low as possible. It is also desirable that a diameter is decreased to a low value enough for coincidence of it with the size of the affected part as much as possible. After the affected part 32 is brought to a given position in a manner described above and a clearance between the magnetic pole pairs is regulated to a given value, the system circuit of a magnetic field applying part B is operated. In which case, a magnetic field is applied from the magnetic pole pairs 14 and 14' toward the affected part 32 of a human body, and a heat generating substance previously embedded in the affected part is increased in temperature. A distance between the two magnetic poles is changeable according to the medical treating portion or the state of a patient.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、交流磁場を発生する癌治療装置、特に本質的
にヒステリシス損失による発熱が期待される強磁性発熱
体を沈着滞留させた癌の患部に、外部から交流磁場を与
え、磁気誘導加熱する、癌の温熱療法に利用する癌治療
装置に関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a cancer treatment device that generates an alternating magnetic field, particularly a cancer treatment device that deposits and retains a ferromagnetic heating element that is expected to generate heat essentially due to hysteresis loss. The present invention relates to a cancer treatment device used for thermotherapy of cancer, which applies an alternating magnetic field to the affected area from the outside to perform magnetic induction heating.

(従来の技術) −aに癌細胞は熱に弱り、43°C付近まで加熱される
と、増殖能力を失い、やがて死滅すると言われている0
例えば抗癌剤や放射線を使った治療では、生き残った癌
細胞が再び増殖する可能性があるが、43℃の高温ダメ
ージを受けた癌細胞は、生き残っても再び増殖すること
がないというのが学会の定説である。しかも癌の患部は
血流が少ないので、周囲に比べて加熱され易いため、癌
の患部を局部的に加熱する温熱療法はきわめて有効な癌
の治療法である。
(Prior art) Cancer cells are said to be sensitive to heat, and when heated to around 43°C, they lose their ability to proliferate and eventually die.
For example, in treatments using anticancer drugs or radiation, there is a possibility that surviving cancer cells will proliferate again, but the academic society says that cancer cells that have been damaged by high temperatures of 43 degrees Celsius will not proliferate again even if they survive. This is a well-established theory. Moreover, since the affected area of cancer has less blood flow, it is more easily heated than the surrounding area, so thermotherapy that locally heats the affected area of cancer is an extremely effective cancer treatment method.

従来、癌の患部を加熱する方法としては、温水、赤外線
、超音波、電磁波などが試みられ、そのための装置が一
部は製品化されているものもある。
Conventionally, hot water, infrared rays, ultrasonic waves, electromagnetic waves, etc. have been tried as methods for heating the affected area of cancer, and some devices for this purpose have even been commercialized.

これらの方法は、いずれも人体の組織そのものに直接熱
を発生あるいは付与させる方式であるため、当然周囲の
正常細胞をも同時に加熱することになり、そのための有
害影響をも考慮しなければならない、また、特に深部に
癌の患部が存在する場合には、人体の表面近傍ばかり温
まり易く、肝心の癌の患部を有効に加温することは容易
でない。
Since all of these methods generate or apply heat directly to the tissue of the human body, they naturally heat surrounding normal cells at the same time, and the harmful effects of this must also be taken into account. In addition, especially when the cancerous area is deep, it is easy to warm only the surface area of the human body, and it is not easy to effectively heat the important cancerous area.

そこで、深部の加熱を効果的に行うべくより低い周波数
の加熱源を選択すれば、人体のMi織を熱発生源として
利用できず、熱発生の媒体を別に用いることになる。そ
のような熱発生の媒体については、現在のところsus
430m、低キユリー点のNi−Cu合金などを用いて
いる(日本ハイパーサーミア誌3(2); 155〜l
63)。しかし、生体内は非常に苛酷な環境下にあり、
これらの合金を長時間生体内に埋入することは不可能で
ある。。
Therefore, if a heating source with a lower frequency is selected to effectively heat the deep part, the Mi fabric of the human body cannot be used as a heat generation source, and a separate heat generation medium must be used. At present, such heat generation media are
430 m, low Curie point Ni-Cu alloy etc. are used (Japan Hyperthermia Magazine 3(2); 155~l
63). However, the inside of a living body is under an extremely harsh environment.
It is impossible to implant these alloys in vivo for long periods of time. .

そこで本発明者らは、様々な実験によりセラミックス材
料を用いた磁気ヒステリシス…による発熱を利用すると
、粉末でも癌の治療に十分な程度の発熱量が得られ、し
かも生体に対して為害性が無く長期間生体内に埋入可能
であることを確認し、その詳細を特願昭63−2387
86号に明らかにした。
Accordingly, the present inventors have found through various experiments that by utilizing heat generated by magnetic hysteresis using ceramic materials, even powder can generate enough heat to treat cancer, and is not harmful to living organisms. It was confirmed that it could be implanted in the living body for a long period of time, and the details were published in patent application No. 63-2387.
This was revealed in issue 86.

また、それに必要な交流磁場発生装置に関して印加磁場
の大きさ、適正周波数を、特開平1−244767号公
報に明らかにしている。
Furthermore, the magnitude and appropriate frequency of the applied magnetic field regarding the alternating current magnetic field generator necessary for this purpose are disclosed in Japanese Patent Laid-Open No. 1-244767.

(発明が解決しようとする課題) ここに、本発明の目的は、上述のような磁気ヒステリシ
ス損失が大きな物質を沈着滞留させた生体色部を実際の
治療の際して十分効率よく加熱できる外部磁気誘導加熱
を備えた癌治療装置を堤供することである。
(Problems to be Solved by the Invention) It is an object of the present invention to provide an external device that can heat the biological color area in which a substance with a large magnetic hysteresis loss as described above is deposited and retained, with sufficient efficiency during actual treatment. The present invention provides a cancer treatment device with magnetic induction heating.

(課題を解決するための手段) 本発明は、かかる目的を達成すべく、上述の2つの発明
の開示する技術手段を用いて、更に人体に応用できる大
きさの装置で各種実験を行った結果、対向式コイルによ
る交流磁場の印加によって上述の目的達成が可能である
ことを知り、本発明を完成した。
(Means for Solving the Problems) In order to achieve the above object, the present invention uses the technical means disclosed in the above-mentioned two inventions, and is the result of various experiments conducted using a device of a size that can be applied to the human body. discovered that the above-mentioned objective could be achieved by applying an alternating current magnetic field using opposed coils, and completed the present invention.

すなわち、本発明は、患部を挟持する位置に離間距離調
整自在に対向設置された交流磁場発生用の磁極対と、該
磁極対に交流磁場を印加するための磁場印加部と、前記
交流磁場を制御するための磁場制御部とから構成される
ことを特徴とする癌治療装置である。
That is, the present invention includes: a pair of magnetic poles for generating an alternating magnetic field, which are installed facing each other at positions that sandwich an affected area so that the separation distance can be freely adjusted; a magnetic field applying section for applying an alternating magnetic field to the pair of magnetic poles; This cancer treatment device is characterized by comprising a magnetic field control section for controlling the magnetic field.

ここに、上記磁極対は、一方から他方へ向かう磁場を形
成し、その間に患部を配置し、予め埋入された発熱体の
みを局部的に加熱する形態のものである。かかる作用効
果を奏する限り、特定の形態のそれに制限されないこと
は本明細書の記載からも当業者には明らかであろう。こ
れはいわば磁場方式とも呼ぶべきものである。
Here, the magnetic pole pair is of a type that forms a magnetic field directed from one side to the other, places the affected area between them, and locally heats only the heating element that has been implanted in advance. It will be clear to those skilled in the art from the description of this specification that the present invention is not limited to a specific form as long as it achieves such effects. This can be called a magnetic field method.

つまり、磁気ヒステリシス損失が大なる物質を予め、そ
の癌部分に沈着1留させた患部を磁極対で挟持すること
により、該磁極対の間で発生する交流磁場を可及的小に
絞ることにより、患部のみの加熱をより効果的に行うこ
とができるからで、この点従来は単にコイルが形成する
磁場内に上記患部を持ち来すだけでよいとの認識しかな
かったのであった。本発明の場合、各コイルの径を小さ
くすればそれだけ局部加熱が可能となる。
In other words, by pre-depositing a substance with large magnetic hysteresis loss on the cancerous area and holding the affected area between a pair of magnetic poles, the alternating magnetic field generated between the pair of magnetic poles is narrowed down to the lowest possible level. This is because only the affected area can be heated more effectively, and in the past, it was only recognized that it was sufficient to simply bring the affected area into the magnetic field formed by the coil. In the case of the present invention, the smaller the diameter of each coil, the more localized heating becomes possible.

磁極対を離間領域の中の狭い範囲内に上記患部が位置す
るため、局部加熱がより効果的に行われ、患部以外の部
位の損傷を可及的小とすることができるのである。
Since the affected area is located within a narrow range within the area separating the magnetic pole pairs, local heating can be performed more effectively and damage to areas other than the affected area can be minimized.

かくして、本発明によれば、次の点で従来の単一コイル
方式と比較して実用上から優れているということができ
る。
Thus, according to the present invention, it can be said that it is practically superior to the conventional single coil system in the following points.

(1)より均一な磁場空間が得られるので発熱量が変動
しにくい、これらの比較を第1図にグラフで示す0図中
、実線で示すのが本発明の磁極方式による磁場の強さと
水平方向距離との関係であり、一方点線で示すのが従来
法のコイル方式によるそれである。磁場の最大強さは同
一レベルに到達できるがもれ磁束が大きすぎる。一方、
本発明方式によれば磁場の均一性および局在性が顕著で
ある。より効率的な加熱が可能となることが分かる。通
常、1ljXの径は最大直径約100−程度であるため
、それに合わせてコイル径を考えればよい。
(1) A more uniform magnetic field space is obtained, so the amount of heat generation is less likely to fluctuate. These comparisons are shown graphically in Figure 1. In Figure 1, the solid line shows the strength of the magnetic field due to the magnetic pole method of the present invention and the horizontal This is the relationship with the directional distance, and the dotted line shows the relationship with the conventional coil method. Although the maximum strength of the magnetic field can reach the same level, the leakage magnetic flux is too large. on the other hand,
According to the method of the present invention, the uniformity and localization of the magnetic field are remarkable. It can be seen that more efficient heating is possible. Normally, the maximum diameter of 1ljX is about 100 mm, so the coil diameter can be determined accordingly.

(2)腫瘍およびその周辺だけを磁場空間に置くことが
できるので、装置がコンパクトになりしかも安全性が高
い。
(2) Only the tumor and its surroundings can be placed in the magnetic field space, making the device compact and highly safe.

(3)横方間に自由な空間があり働者の出入りがスムー
ズ、異常の場合にはすぐにも避難できる。
(3) There is free space between the sides, allowing workers to move in and out smoothly, and in the event of an emergency, they can evacuate immediately.

(4)医師の治療操咋がし易い。(4) It is easy for doctors to administer treatment.

本発明によりそのような優れた利点が得られる理由は、
磁極対を利用し、l振方式として狭い領域に磁場を集中
させたからである。
The reason why the present invention provides such excellent advantages is as follows.
This is because a pair of magnetic poles is used to concentrate the magnetic field in a narrow area as an oscillation method.

(作用) 以下、図面を参照し実施例に基づいて本発明にかかる癌
治療装置(以下、単に本発明装置ということもある)の
具体的構成について説明する。
(Operation) Hereinafter, the specific configuration of the cancer treatment device according to the present invention (hereinafter also simply referred to as the device of the present invention) will be described based on Examples with reference to the drawings.

第2図は、本発明装置の構成を概略説明するブロック図
である。
FIG. 2 is a block diagram schematically explaining the configuration of the apparatus of the present invention.

図示のように、本発明装置は、適宜手段でその離間距離
を調整自在とされ、対向式に設置された磁場発生用の磁
極対14.14’ と、ブレーカ16、トランス18、
パワー調整回路20、そして所定周波数とする周波数発
振回路22から構成される磁場印加部Bと、CPU装置
24、デイスプレィ26、スイッチコントロール回路2
8そして測温センサー3oから構成される磁場制御部C
とを備えている。
As shown in the figure, the device of the present invention includes a pair of magnetic poles 14 and 14' for generating a magnetic field, which are installed in a facing manner and whose separation distance can be adjusted by appropriate means, a breaker 16, a transformer 18,
A magnetic field application section B consisting of a power adjustment circuit 20 and a frequency oscillation circuit 22 for setting a predetermined frequency, a CPU device 24, a display 26, and a switch control circuit 2.
8 and a magnetic field control section C consisting of a temperature sensor 3o.
It is equipped with

パワー調整にサイリスターを用い、周波数調整にトラン
ジスター回路を用いてもよく、磁場の確保のため、コイ
ルを多重に巻いても良く、コイルへの冷却水の圧填が増
大する場合は、別に冷却水用のポンプとタンク (図示
せず)を用いても良い。
A thyristor may be used for power adjustment, a transistor circuit may be used for frequency adjustment, the coil may be wound multiple times to secure the magnetic field, and if the pressure of cooling water into the coil increases, separate cooling water may be used. A commercial pump and tank (not shown) may be used.

なお、必要時にはA/Dコンバーターを通して測温セン
サー30をCPUに接続しても良い、また、CPUによ
らずFDI制御のできるコントローラを用いても良い。
Note that, if necessary, the temperature sensor 30 may be connected to the CPU through an A/D converter, or a controller that can perform FDI control without depending on the CPU may be used.

上記対向式磁極対14.14゛ は、例えば図示例のよ
うに上下方向に離間設置されてもよく、さらに必要によ
り、水平に設置されてもよい。コイル内のフェライト製
のコア15の作用は、作用させる磁場強度を高めるため
である。
The opposed magnetic pole pairs 14.14' may be spaced apart in the vertical direction, for example as in the illustrated example, or may be installed horizontally if necessary. The effect of the ferrite core 15 in the coil is to increase the strength of the applied magnetic field.

次に、本発明装置を使用して患部の加熱治療を行う際の
装置の操作法について説明する。
Next, a method of operating the device of the present invention when performing heat treatment on an affected area using the device will be explained.

まず、加温治療を行う人体の患部32に、磁気ヒステリ
シス損失が大なる物質を予め、その癌部分に沈着滞留さ
せ、該患部32に例えばLuxtron製蛍光型温度プ
ローブの温度センサー30を刺入する。
First, a substance with a large magnetic hysteresis loss is deposited and retained in the cancerous part 32 of the human body to be subjected to heating treatment, and a temperature sensor 30, such as a fluorescent temperature probe manufactured by Luxtron, for example, is inserted into the affected part 32. .

このときの磁気ヒステリシス損失が大なる物質とは、例
えば生体親和性のあるセラミックガラス物質を使用すれ
ばよいが、特にそれだけに制服はされない。生体親和性
を有し、しかも内部にマグネタイト、フェライトなどを
析出させたセラミックス、あるいは結晶化ガラスなどを
用いた場合には、その発熱効率は一層改善される。
The material with large magnetic hysteresis loss at this time may be, for example, a biocompatible ceramic glass material, but this is not the only material. If biocompatible ceramics or crystallized glass, in which magnetite, ferrite, etc. are precipitated, are used, the heat generation efficiency will be further improved.

次に、対問して設置されたM1掻対14.14°の間に
該患部32が置かれるように磁極対を配置する。
Next, the magnetic pole pair is arranged so that the affected part 32 is placed between the M1 poles 14.14 degrees that are set oppositely.

両者の先端部の離間距離は可及的小とするのが加熱効率
から好ましい。また直径も患部の大きさに可及的に一致
する程度に小さくするのがよい。このときの周波数はこ
れも前述の特開平1−244767号公報に開示された
ように100〜300kHz周波数で5000e以下の
交流磁場とするのが好ましい。
In terms of heating efficiency, it is preferable that the distance between the two tips be as small as possible. It is also preferable to make the diameter as small as possible to match the size of the affected area. The frequency at this time is preferably an alternating magnetic field of 5000 e or less at a frequency of 100 to 300 kHz, as also disclosed in the above-mentioned Japanese Patent Application Laid-Open No. 1-244767.

このように患部32が所定位置に持ち来され、磁極対の
離間距離も所定値に調整されてから、磁場印加部Bの系
統回路を作動させると、磁極対14.14゛ から人体
の患部32に向は磁場が印加され、予め患部に埋め込ま
れている発熱体が昇温する。二つの磁極の間隔は、各々
の患者の治療部位あるいは状態に合わせて変えることが
できる。併せて、前述したごとく、患部を42〜45°
Cの範囲で加温し続けるのが望ましい。
After the affected part 32 is brought to a predetermined position and the separation distance between the magnetic pole pairs is adjusted to a predetermined value, when the system circuit of the magnetic field application section B is activated, the magnetic pole pair 14. A magnetic field is applied in the opposite direction, raising the temperature of a heating element that has been previously embedded in the affected area. The spacing between the two magnetic poles can be varied depending on the treatment area or condition of each patient. In addition, as mentioned above, hold the affected area at 42 to 45 degrees.
It is desirable to continue heating within the range of C.

患部の加熱温度は温度センサー30により検出され、C
PU装置24を通じてパワー調整回路20に入力され、
パワー調整回路20は、患部32の温度が低い場合には
、その出力を増し患部温度を上昇させ、一方、患部32
の温度が高いときには、その出力を減じ患部温度を低下
させる。このときの状況は必要によりデイスプレィ26
に適宜表示させてもよい。
The heating temperature of the affected area is detected by the temperature sensor 30, and C
is input to the power adjustment circuit 20 through the PU device 24,
When the temperature of the affected area 32 is low, the power adjustment circuit 20 increases its output to raise the temperature of the affected area.
When the temperature is high, its output is reduced to lower the temperature of the affected area. At this time, display 26 as necessary.
may be displayed as appropriate.

このようにして、患部の温度は常に42〜45°Cの範
囲にあるように調整される。本発明によればこのような
温度調節は自動的に行われる。
In this way, the temperature of the affected area is regulated so that it is always within the range of 42-45°C. According to the invention, such temperature regulation is performed automatically.

次に、実施例によって本発明の効果をさらに具体的に説
明する。
Next, the effects of the present invention will be explained in more detail with reference to Examples.

実施例 第2図に示す装置を使い、200V、3相出力25kW
で100kHz、2000eの交流磁場の下での加熱試
験を行った。熱発生媒、つまり被誘導加熱体としては、
Cab、 5i02+ FexO:+ B2O3および
P2O,を含有する生体活性結晶化ガラスを用いた。
Example Using the device shown in Figure 2, 200V, 3-phase output 25kW
A heating test was conducted under an alternating current magnetic field of 100 kHz and 2000 e. As a heat generating medium, that is, an object to be heated by induction,
A bioactive crystallized glass containing Cab, 5i02+ FexO:+ B2O3 and P2O was used.

磁極対14.14°の離間圧M 250mm、直径15
0mmであった。患部に埋入した上記被誘導加熱体は直
径2〜3慣−の球状のものであった。この被誘導発熱体
を生体の軟部組繊をシミュレートした寒天で覆った。こ
の寒天は厚さ約30cmであるが、その部分の温度上昇
はほとんど認められなかった。
Magnetic pole pair 14.14° separation pressure M 250mm, diameter 15
It was 0 mm. The induced heating body implanted in the affected area was spherical with a diameter of 2 to 3 mm. This induced heating element was covered with agar that simulated the soft tissues of a living body. Although this agar was approximately 30 cm thick, almost no temperature increase was observed in that area.

このときの加熱曲線を第3図に示す。横軸は経過時間を
、縦軸は到達温度を示す。第3図の結果からも明らかな
ように43゛Cにまで約1分で到達した。43“Cに到
達した後は磁場の低下、すなわち、磁極対14.14″
に流れる電流の低下の手段によってその温度を保持した
。図中、点線は磁場の強さの変化を一般的傾向として示
す。
The heating curve at this time is shown in FIG. The horizontal axis shows the elapsed time, and the vertical axis shows the reached temperature. As is clear from the results shown in Figure 3, the temperature reached 43°C in about 1 minute. After reaching 43"C the magnetic field decreases, i.e. the magnetic pole pair 14.14"
The temperature was maintained by means of a reduction in the current flowing through the tube. In the figure, dotted lines indicate changes in magnetic field strength as a general trend.

(発明の効果) 以上のように、本発明装置は極めて取扱が容易でしかも
癌の患部だけを効果的に温めることができ、癌の治療に
を効である。
(Effects of the Invention) As described above, the device of the present invention is extremely easy to handle and can effectively heat only the affected area of cancer, making it effective in cancer treatment.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、コイルの水平方向距離とfff場の強さとの
関係を示すグラフ 第2図は、本発明装置のブロンク図;および第3図は、
実施例における加熱状況を示すグラフである。 14;磁極      15; コア 16: ブレーカ     18ニドランス20:パワ
ー調整回1B22:周波数発振回路24:CPU   
    26; デイスプレィ28:スイッチコントロ
ール回路 30: 測温センサー
FIG. 1 is a graph showing the relationship between the horizontal distance of the coil and the strength of the fff field; FIG. 2 is a bronch diagram of the device of the present invention; and FIG.
It is a graph showing a heating situation in an example. 14; Magnetic pole 15; Core 16: Breaker 18 Nidorance 20: Power adjustment circuit 1B22: Frequency oscillation circuit 24: CPU
26; Display 28: Switch control circuit 30: Temperature sensor

Claims (1)

【特許請求の範囲】[Claims]  患部を挟持する位置に離間距離調整自在に対向設置さ
れた交流磁場発生用の磁極対と、該磁極対に交流磁場を
印加するための磁場印加部と、前記交流磁場を制御する
ための磁場制御部とから構成されることを特徴とする癌
治療装置。
A pair of magnetic poles for generating an alternating magnetic field, which are arranged opposite to each other at positions that sandwich the affected area so that the separation distance can be freely adjusted; a magnetic field applying section for applying an alternating magnetic field to the pair of magnetic poles; and a magnetic field control for controlling the alternating magnetic field. A cancer treatment device comprising:
JP1296679A 1989-11-15 1989-11-15 Cancer medical treating device Pending JPH03158176A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1296679A JPH03158176A (en) 1989-11-15 1989-11-15 Cancer medical treating device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1296679A JPH03158176A (en) 1989-11-15 1989-11-15 Cancer medical treating device

Publications (1)

Publication Number Publication Date
JPH03158176A true JPH03158176A (en) 1991-07-08

Family

ID=17836675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1296679A Pending JPH03158176A (en) 1989-11-15 1989-11-15 Cancer medical treating device

Country Status (1)

Country Link
JP (1) JPH03158176A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006252A1 (en) * 1998-07-28 2000-02-10 Pulse Medical Co., Ltd. Electromagnet for magnetotherapeutic device, coil for magnetotherapeutic device, and magnetotherapeutic device
WO2009119236A1 (en) * 2008-03-26 2009-10-01 テルモ株式会社 Treatment apparatus
WO2018097185A1 (en) 2016-11-24 2018-05-31 公立大学法人横浜市立大学 Cancer treatment apparatus
US11730956B2 (en) 2018-05-23 2023-08-22 Ricoh Company, Ltd. Power supply apparatus and magnetic field generation system

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006252A1 (en) * 1998-07-28 2000-02-10 Pulse Medical Co., Ltd. Electromagnet for magnetotherapeutic device, coil for magnetotherapeutic device, and magnetotherapeutic device
WO2009119236A1 (en) * 2008-03-26 2009-10-01 テルモ株式会社 Treatment apparatus
WO2018097185A1 (en) 2016-11-24 2018-05-31 公立大学法人横浜市立大学 Cancer treatment apparatus
US11383094B2 (en) 2016-11-24 2022-07-12 Public University Corporation Yokohama City University Cancer treatment apparatus
EP4302820A2 (en) 2016-11-24 2024-01-10 Public University Corporation Yokohama City University Cancer treatment apparatus
US11730956B2 (en) 2018-05-23 2023-08-22 Ricoh Company, Ltd. Power supply apparatus and magnetic field generation system

Similar Documents

Publication Publication Date Title
Short et al. Physical hyperthermia and cancer therapy
Brezovich et al. Local hyperthermia with interstitial techniques
Babincova et al. Blood-specific whole-body electromagnetic hyperthermia
JP5490090B2 (en) Apparatus for applying an alternating magnetic field for heating magnetic fluid in a body part of a patient
JP2014525290A5 (en)
US20200254272A1 (en) System and methods for treating cancer cells with alternating polarity magnetic fields
JPS6131174A (en) Warming apparatus for hyperthermia
KR20170115951A (en) Device for Alternating Current Magnetic Field-induced Hyperthermia
US11931593B2 (en) System and methods for treating cancer cells with alternating polarity magnetic fields
US7258658B2 (en) Method and apparatus for stimulating cellular regeneration in a patient
US11344740B2 (en) System and methods for treating cancer cells with alternating polarity magnetic fields
JPH03158176A (en) Cancer medical treating device
JPH0718357A (en) Combined functional material device
JPH01244767A (en) Cancer remedying device
CA3129257A1 (en) System and methods for treating cancer cells with alternating polarity magnetic fields
CN112423721A (en) Device comprising an object with a heated and biocompatible tip
CN108031008A (en) A kind of accurate temperature controlling magnetic hysteresis heating unit for localized treatment of lesions tissue
CN212038613U (en) Magnetic induction thermotherapy temperature control device
Matsumoto et al. Ferromagnetic hyperthermia in rabbit eyes using a new glass-ceramic thermoseed
US20170119575A1 (en) Method and apparatus utilizing magnetic nanoparticles for performing hyperthermal therapies
JP3234231U (en) Biliary metal stent for tumor thermal ablation under magnetic field
JPS62152474A (en) Magnetic implant heating apparatus
JPS625364A (en) Warming apparatus for hyperthermia
JPH0261036A (en) Temperature sensitive amorphous alloy
JP2005253813A (en) Mri treatment system